Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71876 - 71900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	NOC3L	64318	upregulated	Silicon Dioxide analog results in increased expression of NOC3L mRNA	10q23.33	A24195
Silicon dioxide	Approved	NOL10	79954	upregulated	Silicon Dioxide analog results in increased expression of NOL10 mRNA	2p25.1	A24195
Silicon dioxide	Approved	NOL4	8715	downregulated	Silicon Dioxide analog results in decreased expression of NOL4 mRNA	18q12.1	A24194
Silicon dioxide	Approved	NOL4L	140688	downregulated	Silicon Dioxide analog results in decreased expression of NOL4L mRNA	20q11.21	A24195
Silicon dioxide	Approved	NOL9	79707	upregulated	Silicon Dioxide analog results in increased expression of NOL9 mRNA	1p36.31	A24195
Silicon dioxide	Approved	NOLC1	9221	upregulated	Silicon Dioxide analog results in increased expression of NOLC1 mRNA	10q24.32	A24195
Silicon dioxide	Approved	NONO	4841	downregulated	Silicon Dioxide results in decreased expression of NONO mRNA	Xq13.1	A24196
Silicon dioxide	Approved	NOP56	10528	upregulated	Silicon Dioxide analog results in increased expression of NOP56 mRNA	20p13	A24195
Silicon dioxide	Approved	NOP58	51602	upregulated	Silicon Dioxide analog results in increased expression of NOP58 mRNA	2q33.1	A24195
Silicon dioxide	Approved	NOS1	4842	downregulated	Silicon Dioxide analog results in decreased expression of NOS1 mRNA	12q24.22	A24194 A24195
Silicon dioxide	Approved	NOSTRIN	115677	downregulated	Silicon Dioxide analog results in decreased expression of NOSTRIN mRNA	2q24.3	A24195
Silicon dioxide	Approved	NOTCH3	4854	downregulated	Silicon Dioxide analog results in decreased expression of NOTCH3 mRNA	19p13.12	A24194
Silicon dioxide	Approved	NOV	4856	upregulated	Silicon Dioxide analog results in increased expression of NOV mRNA	8q24.12	A24195
Silicon dioxide	Approved	NOVA1	4857	downregulated	Silicon Dioxide analog results in decreased expression of NOVA1 mRNA	14q12	A24195
Silicon dioxide	Approved	NOX1	27035	downregulated	Silicon Dioxide analog results in decreased expression of NOX1 mRNA	Xq22.1	A24195
Silicon dioxide	Approved	NOX3	50508	downregulated	Silicon Dioxide analog results in decreased expression of NOX3 mRNA	6q25.3	A24195
Silicon dioxide	Approved	NOXA1	10811	downregulated	Silicon Dioxide analog results in decreased expression of NOXA1 mRNA	9q34.3	A24195
Silicon dioxide	Approved	NPAS2	4862	upregulated	Silicon Dioxide analog results in increased expression of NPAS2 mRNA	2q11.2	A24195
Silicon dioxide	Approved	NPC1	4864	upregulated	Silicon Dioxide analog results in increased expression of NPC1 mRNA	18q11.2	A24195
Silicon dioxide	Approved	NPEPL1	79716	downregulated	Silicon Dioxide analog results in decreased expression of NPEPL1 mRNA	20q13.32	A24195
Silicon dioxide	Approved	NPFFR2	10886	upregulated	Silicon Dioxide analog results in increased expression of NPFFR2 mRNA	4q13.3	A24194
Silicon dioxide	Approved	NPHS1	4868	upregulated	Silicon Dioxide analog results in increased expression of NPHS1 mRNA	19q13.12	A24195
Silicon dioxide	Approved	NPHS2	7827	upregulated	Silicon Dioxide analog results in increased expression of NPHS2 mRNA	1q25.2	A24195
Silicon dioxide	Approved	NPIPB5	100132247	upregulated	Silicon Dioxide analog results in increased expression of NPIPB5 mRNA	16p12.2	A24195
Silicon dioxide	Approved	NPM1	4869	upregulated	Silicon Dioxide analog results in increased expression of NPM1 mRNA	5q35.1	A24195

Displaying entries 71876 - 71900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability